542771 — Novateor Research Laboratories Income Statement
0.000.00%
- IN₹348.00m
- IN₹353.51m
- IN₹27.77m
Annual income statement for Novateor Research Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.88 | 7.42 | 12.6 | 12.1 | 27.8 |
Cost of Revenue | |||||
Gross Profit | -0.248 | 2.14 | 3.06 | 2.66 | 9.16 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6.13 | 14.9 | 16.9 | 16.2 | 30.7 |
Operating Profit | -4.26 | -7.44 | -4.34 | -4.11 | -2.91 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.166 | -2.6 | 0.395 | 0.463 | 1.13 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.118 | -2.28 | 0.367 | 0.293 | 0.818 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.118 | -2.28 | 0.367 | 0.293 | 0.818 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.118 | -2.28 | 0.367 | 0.293 | 0.818 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.02 | 0.161 | 0.076 | 0.051 | 0.17 |